Cleared Traditional

K241058 - Lyka PORT Needle Free Access Device (41...

K241058 is the FDA 510(k) clearance for Lyka PORT Needle Free Access Device (41... by Quest Medical, Inc.. It is a Class 2 General Hospital device (product code FPA) cleared through the Traditional 510(k) pathway after a 244-day FDA review.

K241058 · Quest Medical, Inc. · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2024
Decision
244d
Days
Class 2
Risk

K241058 is an FDA 510(k) clearance for the Lyka® PORT Needle Free Access Device (4170Y). Classified as Set, Administration, Intravascular (product code FPA), Class II - Special Controls.

Submitted by Quest Medical, Inc. (Allen, US). The FDA issued a Cleared decision on December 18, 2024 after a review of 244 days - an extended review cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5440 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General Hospital review framework, consistent with the majority of Class II 510(k) submissions.

View all Quest Medical, Inc. devices

Submission Details

510(k) Number K241058 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 18, 2024
Decision Date December 18, 2024
Days to Decision 244 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
115d slower than avg
Panel avg: 129d · This submission: 244d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code FPA Set, Administration, Intravascular
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5440
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FPA Set, Administration, Intravascular

All 445
Devices cleared under the same product code (FPA) and FDA review panel - the closest regulatory comparables to K241058.
JetCan® Pro Safety Huber Needle
K242763 · Pfm Medical, Inc. · May 2025
Solution Administration Sets
K243529 · Baxter Healthcare Corporation · Mar 2025
Intravascular Extension Sets and Accessories
K242339 · Baxter Healthcare Corporation · Feb 2025
Ecomed Disposable Administration Sets
K234129 · Ecomed Solutions, LLC · Sep 2024
I.V. Administration Set
K242126 · Bq Plus Medical Co., Ltd. · Aug 2024
Disposable infusion set with needle
K232475 · Shandong Zhushi Pharmaceutical Group Co., Ltd. · May 2024